mereo-logo-full-colour-rgb.svg

Search

Press Release

Intended for Media and Investors

Raising awareness around Alpha-1 Antitrypsin Deficiency

One of the biggest obstacles with rare diseases is a lack of awareness. This often leads to a delay in diagnosis, and therefore a delay in – or lack of – appropriate treatment. We believe not only in the importance of treatment, but also the importance of awareness. This is why we are committed to working closely with AATD communities to raise awareness of the importance of getting tested.

Welcome

This page is intended for Healthcare Professionals only.

Please confirm that you are a Healthcare Professional.

No